Company profile for Innovent Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our mission is to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people. we have developed our fully-integrated platform which includes R&D, CMC (Chemistry, Manufacturing, and Control), clinical trial and commercialization capabilities. These capabilities have enabled us to build a robust pipeline of innovative and commercially prom...
Our mission is to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people. we have developed our fully-integrated platform which includes R&D, CMC (Chemistry, Manufacturing, and Control), clinical trial and commercialization capabilities. These capabilities have enabled us to build a robust pipeline of innovative and commercially promising monoclonal antibodies and other biologics in the fields of oncology, ophthalmology, autoimmune, and cardiovascular diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
168 Dongping Street, Suzhou Industrial Park,Jiangsu
Telephone
Telephone
(86)0512-69566088
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/chinas-first-domestic-il-23p19-monoclonal-antibody-innovents-pecondle-picankibart-injection-received-nmpa-approval-302627980.html

PR NEWSWIRE
28 Nov 2025

https://www.prnewswire.com/news-releases/mazdutide-9mg-supplementary-application-accepted-for-review-by-chinas-nmpa-potentially-offering-a-novel-drug-option-for-moderate-to-severe-obese-population-302625421.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/innovent-biologics-enters-hang-seng-index-and-two-other-major-indices-global-capital-markets-recognize-leading-innovators-value-302624043.html

PR NEWSWIRE
24 Nov 2025

https://www.prnewswire.com/news-releases/innovent-biologics-enters-hang-seng-index-and-two-other-major-indices-global-capital-markets-recognize-leading-innovators-value-302624043.html

PR NEWSWIRE
24 Nov 2025

https://www.prnewswire.com/news-releases/mazdutide-9-mg-achieves-up-to-20-1-weight-loss-in-chinese-adults-with-obesity-glory-2-study-meets-primary-and-all-key-secondary-endpoints-302620471.html

PR NEWSWIRE
20 Nov 2025

https://www.prnewswire.com/news-releases/innovent-and-sanegenebio-announce-phase-1-clinical-data-for-ibi3016-presented-at-american-heart-association-aha-2025-annual-meeting-302609412.html

PR NEWSWIRE
09 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty